The dual AT1R blockers/PPAR-γ agonist ARB could prevent apoptotic progression through the upregulation of the cardiac SIRT1/PGC-1α pro-survival pathway associated with IGF-II and p-JNK deactivation in hypertension. This evidence concerns the gene SIRT1 and hypertensive disorder.